11-10-2023, 11:21 AM
Demand soars for self-injection weight-loss drugs
Obesity market could be worth $100 bln within a decade-analysts
Contract drugmakers race to expand capacity to fill syringes
By Maggie Fick
LONDON, Oct 9 (Reuters) – Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the injection pens used to administer treatments like Novo Nordisk's Wegovy.
Interviews with a dozen company executives, analysts and investors showed pharmaceutical services companies jostling to secure more of the specialist work of filling the syringes used in the pens, a process known as fill-finish.
Obesity market could be worth $100 bln within a decade-analysts
Contract drugmakers race to expand capacity to fill syringes
By Maggie Fick
LONDON, Oct 9 (Reuters) – Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the injection pens used to administer treatments like Novo Nordisk's Wegovy.
Interviews with a dozen company executives, analysts and investors showed pharmaceutical services companies jostling to secure more of the specialist work of filling the syringes used in the pens, a process known as fill-finish.
I, being poor, have only my dreams; I have spread my dreams under your feet; Tread softly because you tread on my dreams.